Libya – The American biopharmaceutical company Emmaus has entered into an exclusive distribution agreement with the National International Company for Pharmaceuticals and Medical Supplies to strengthen its commercial presence in Libya.
According to a report published by the US website Stock Titan, the partnership aims to expand Emmaus’s international footprint and boost its position in North Africa through the Libyan market.
J.B. Choi, managing director for the Middle East and Africa at Emmaus, said the company’s entry into Libya is a significant step in its international expansion strategy.
